Orca Capital AG - Apr 14, 2025 SCHEDULE 13G Report for Can-Fite BioPharma Ltd. Ordinary Shares, no par value (CANF)

Filing Manager: Orca Capital AG
Reporting Manager: Orca Capital AG
Security: Can-Fite BioPharma Ltd. Ordinary Shares, no par value
Symbol: CANF
Shares outstanding: 3.87B shares
Disclosed Ownership: 375M shares
Ownership: 9.7%
Form type: SCHEDULE 13G
Date filed: 4/16/2025, 04:30 PM
Date of event: Apr 14, 2025
Next filing: Apr 23, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Orca Capital AG	9.7%	375M	375M	0	/s/ Thomas Konig	Thomas Konig/Director